9-128322938-G-T
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016035.5(COQ4):c.70+10G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
COQ4
NM_016035.5 intron
NM_016035.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.628
Publications
0 publications found
Genes affected
COQ4 (HGNC:19693): (coenzyme Q4) This gene encodes a component of the coenzyme Q biosynthesis pathway. Coenzyme Q, an essential component of the electron transport chain, shuttles electrons between complexes I or II to complex III of the mitochondrial transport chain. This protein appears to play a structural role in stabilizing a complex that contains most of the coenzyme Q biosynthesis enzymes. Mutations in this gene are associated with mitochondrial disorders linked to coenzyme Q deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
COQ4 Gene-Disease associations (from GenCC):
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COQ4 | NM_016035.5 | c.70+10G>T | intron_variant | Intron 1 of 6 | ENST00000300452.8 | NP_057119.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COQ4 | ENST00000300452.8 | c.70+10G>T | intron_variant | Intron 1 of 6 | 1 | NM_016035.5 | ENSP00000300452.3 | |||
| COQ4 | ENST00000372875.3 | c.70+10G>T | intron_variant | Intron 1 of 3 | 2 | ENSP00000361966.3 | ||||
| COQ4 | ENST00000608951.5 | c.70+10G>T | intron_variant | Intron 1 of 2 | 2 | ENSP00000476323.1 | ||||
| COQ4 | ENST00000609948.1 | c.70+10G>T | intron_variant | Intron 1 of 1 | 2 | ENSP00000477292.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1450106Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 721524
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1450106
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
721524
African (AFR)
AF:
AC:
0
AN:
33152
American (AMR)
AF:
AC:
0
AN:
44340
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25990
East Asian (EAS)
AF:
AC:
0
AN:
39516
South Asian (SAS)
AF:
AC:
0
AN:
85998
European-Finnish (FIN)
AF:
AC:
0
AN:
45102
Middle Eastern (MID)
AF:
AC:
0
AN:
5708
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1110292
Other (OTH)
AF:
AC:
0
AN:
60008
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.